<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9502015</journal-id>
<journal-id journal-id-type="pubmed-jr-id">8791</journal-id>
<journal-id journal-id-type="nlm-ta">Nat Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Nat. Med.</journal-id>
<journal-title-group>
<journal-title>Nature medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1078-8956</issn>
<issn pub-type="epub">1546-170X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28024084</article-id>
<article-id pub-id-type="pmc">5589073</article-id>
<article-id pub-id-type="doi">10.1038/nm.4257</article-id>
<article-id pub-id-type="manuscript">NIHMS892384</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader–Willi syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Yuna</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Hyeong-Min</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN2">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiong</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sciaky</surname>
<given-names>Noah</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hulbert</surname>
<given-names>Samuel W</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cao</surname>
<given-names>Xinyu</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Everitt</surname>
<given-names>Jeffrey I</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jin</surname>
<given-names>Jian</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roth</surname>
<given-names>Bryan L</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Yong-hui</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Pediatrics, School of Medicine, Duke University, Durham, North Carolina, USA</aff>
<aff id="A2">
<label>2</label>Department of Cell Biology and Physiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA</aff>
<aff id="A3">
<label>3</label>Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA</aff>
<aff id="A4">
<label>4</label>Departments of Pharmacological Sciences and Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA</aff>
<aff id="A5">
<label>5</label>Department of Neurobiology, School of Medicine, Duke University, Durham, North Carolina, USA</aff>
<aff id="A6">
<label>6</label>Department of Pathology, School of Medicine, Duke University, Durham, North Carolina, USA</aff>
<aff id="A7">
<label>7</label>Program in Neuroscience, Division of Chemical Biology and Medicinal Chemistry, and NIMH Psychoactive Drug Screening Program, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA</aff>
<aff id="A8">
<label>8</label>Program in Genetics and Genomics, School of Medicine, Duke University, Durham, North Carolina, USA</aff>
<author-notes>
<corresp id="FN1">Correspondence should be addressed to B.L.R. (<email>bryan_roth@med.unc.edu</email>) or Y.-H.J. (<email>yong-hui.jiang@duke.edu</email>)</corresp>
<fn fn-type="equal" id="FN2">
<label>9</label>
<p>These authors contributed equally to this work.</p>
</fn>
<fn fn-type="COI-statement" id="FN5">
<p>
<bold>COMPETING FINANCIAL INTERESTS</bold>
</p>
<p>The authors declare no competing financial interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>14</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>26</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>07</day>
<month>9</month>
<year>2017</year>
</pub-date>
<volume>23</volume>
<issue>2</issue>
<fpage>213</fpage>
<lpage>222</lpage>
<!--elocation-id from pubmed: 10.1038/nm.4257-->
<permissions>
<license license-type="permissions-link">
<license-p>Reprints and permissions information is available online at <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/reprints/index.html">http://www.nature.com/reprints/index.html</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">Prader–Willi syndrome (PWS) is an imprinting disorder caused by a deficiency of paternally expressed gene(s) in the 15q11–q13 chromosomal region. The regulation of imprinted gene expression in this region is coordinated by an imprinting center (PWS-IC). In individuals with PWS, genes responsible for PWS on the maternal chromosome are present, but repressed epigenetically, which provides an opportunity for the use of epigenetic therapy to restore expression from the maternal copies of PWS-associated genes. Through a high-content screen (HCS) of &gt;9,000 small molecules, we discovered that UNC0638 and UNC0642—two selective inhibitors of euchromatic histone lysine <italic>N</italic>-methyltransferase-2 (EHMT2, also known as G9a)—activated the maternal (m) copy of candidate genes underlying PWS, including the SnoRNA cluster <italic>SNORD116</italic>, in cells from humans with PWS and also from a mouse model of PWS carrying a paternal (p) deletion from small nuclear ribonucleoprotein N (<italic>Snrpn</italic> (<italic>S</italic>)) to ubiquitin protein ligase E3A (<italic>Ube3a</italic> (<italic>U</italic>)) (mouse model referred to hereafter as <italic>m<sup>+</sup>/p<sup>ΔS−U</sup></italic>). Both UNC0642 and UNC0638 caused a selective reduction of the dimethylation of histone H3 lysine 9 (H3K9me2) at PWS-IC, without changing DNA methylation, when analyzed by bisulfite genomic sequencing. This indicates that histone modification is essential for the imprinting of candidate genes underlying PWS. UNC0642 displayed therapeutic effects in the PWS mouse model by improving the survival and the growth of <italic>m<sup>+</sup>/p<sup>ΔS−U</sup></italic> newborn pups. This study provides the first proof of principle for an epigenetics-based therapy for PWS.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>